FMC-376

· Frontier Medicines Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FMC-376, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors [Phase 1, Phase 2]